• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Smell test identifies AD risk

Article

Just when the medical community is becoming excited about PET for Alzheimer's disease, along comes a new nemesis, the scratch-and-sniff test. Apparently, in Alzheimer's, the nose knows.

Just when the medical community is becoming excited about PET for Alzheimer's disease, along comes a new nemesis, the scratch-and-sniff test. Apparently, in Alzheimer's, the nose knows.

Autopsy results have indicated that the nerve pathways involved in smell are affected at an early stage in the brains of Alzheimer's pa-tients. Researchers at Columbia University have pinpointed 10 specific odors that patients with early Alzheimer's cannot identify: clove, leather, lemon, lilac, menthol, natural gas, pineapple, smoke, soap, and strawberry. The inability to identify these specific odors predicted who would go on to develop AD, according to Dr. Davangere Devanand and colleagues, who presented the findings at the American Col-lege of Neuropsychopharmacology meeting in December.

Devanand had ear-lier found a global relationship between loss of smell and Alzheimer's. But knowing the specific odors involved can help physicians make a definitive diagnosis and start therapy earlier, he said.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.